baber/WOPTO huggingface dataset:
Patent IL-62042-A0 (IL)
Title: Substituted 3-(1,2-dibromo-alkyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid esters.their preparation and their use as pesticides
IPC: A01N53/02
Filed: 1981-02-02
Abstract: Substituted 3-(1,2-dibromo-alkyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid esters of the formula   <IMAGE>    in which R1 is halogen or optionally substituted phenyl or optionally substituted alkyl, R2 is hydrogen, halogen or optionally substituted alkyl, and Y is the radical of an alcohol customary in pyrethroids, with the proviso that Y is a benzyloxy radical which is substituted by halogen and optionally substituted by at least one additional radical if R1 is halogen or methyl, which possess pesticidal properties. The acid moieties of such esters wherein R1 is optionally substituted phenyl are new compounds.
Patent IL-79207-A0 (IL)
Title: Pharmaceutical compositions containing terguide
IPC: C07D457/12
Filed: 1986-06-24
Abstract: Terguride and its physiologically compatible salts can be used for the treatment of geriatric deficiencies, e.g., in doses of 0.1-5.0 mg/day.
Patent IL-84891-A0 (IL)
Title: Optically active tetrahydro-2-furanone derivative,its preparation and its use as microbicide
IPC: C07D307/32
Filed: 1987-12-21
Abstract: The (aS,1'R) enantiomer and the (aR,1'S)(aS,1'R) pair of enantiomers and the (aR,1'R)(aS,1'R) diastereomer of the compound of the formula <IMAGE> are potent plant microbicides. They can be obtained partly from the racemate by physicochemical separation methods and partly by targeted chemical synthesis.
Patent IL-93443-A0 (IL)
Title: Trifluoromethylphenylazolyl-methyloxirane derivatives and fungicides containing these compounds
IPC: A01N43/50
Filed: 1990-02-19
Abstract: Trifluoromethylphenylazolylmethyloxiranes of the general formula I <IMAGE>  in which R<1> represents hydrogen, halogen, nitro, phenyl, phenoxy, alkyl, alkoxy, haloalkyl or haloalkoxy, and, moreover, R<1> together with the phenyl ring can also form a naphthyl radical which is unsubstituted or substituted,  n represents an integer from 1 to 5,  R<2> represents ortho- or para-trifluoromethyl,  X represents CH or N, and their acid addition salts and metal salts which are tolerated by plants, and fungicides containing these compounds.
Patent IL-100046-A0 (IL)
Title: 4-benzoyl isoxazole derivatives
IPC: C07D261/14
Filed: 1991-11-13
Abstract: 4-Benzoyl isoxazole derivatives of the formula I: <CHEM>  wherein: R represents alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, optionally substituted cycloalkyl, -CO2R<3>,-COR<5>,cyano,nitro, -CONR<3><1>R<4> or a halogen atom;  R<1> represents :- hydrogen , alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl or optionally substituted cycloalkyl  R<2> represents :- halogen, R<5>, -SR<5>, -SOR<5>, -SO2R<5>, -SO2NR<3><1>R<4>,-CO2R<3>, -COR<5>, -CONR<3><1>R<4>, -CSNR<3><1>R<4>, -OR<5>, a nitro group, a cyano group, a group -O(CH2)q-OR<5> or alkyl substituted by OR<5>; R<3>, R<3><1> and R<4>, which may be the same or different, each represents:-     hydrogen, alkyl or haloalkyl;     R<5> represents alkyl or haloalkyl;     n represents an integer from 1 to 5; and     q represents an integer from 1 to 3; and agriculturally acceptable salts thereof and their use as herbicides is described.
Patent IL-100343-A0 (IL)
Title: G protein coupled glutamate receptors
IPC: C07K19/00
Filed: 1991-12-11
Abstract: Mammalian G protein coupled glutamate receptors are identified, isolated and purified. The receptors have been cloned, sequenced and expressed by recombinant means. The receptors and antibodies thereby may be used to identify agonists and antagonists of G protein coupled glutamate receptor mediated neuronal excitation, as well as in methods of diagnosis.
Patent IL-102004-A0 (IL)
Title: Heterocyclic substituted 2-acylamino-5-thiazoles,their preparation and pharmaceutical compositions containing them
IPC: C07D417/12
Filed: 1992-05-26
Abstract: These compounds correspond to the formula: 
<IMAGE>
 in which R1 represents H or an alkyl, phenylalkyl, aminoalkyl, optionally esterified carboxyalkyl, cyanoalkyl, carbamoylalkyl, hydroxyalkyl or alkoxyalkyl group; RIV represents an optionally substituted cycloalkyl group or an aromatic group such as an optionally substituted phenyl or heterocycle or RIV and RV together represent the group: 
<IMAGE>
 in which u has the value 1 to 3, optionally carrying (np) substituents Xp chosen from halogen, alkyl, alkoxy, nitro and trifluoromethyl, and np have a value from 0 to 3; RV represents a group (CH2)m-X in which m is 0 to 5 and X represents a halogen, a cycloalkyl, an optionally substituted phenyl, a group COOX1; -O-COX1; -SCOX1; (O)q-S-X1 with q = 0, 1 or 2; -O-COOX1; -N-X3-CO-X1 with X3 = H or alkyl; 
<IMAGE>
 with W = O or S and X1 being a C1 to C3 alkyl or an optionally substituted phenyl; a group -COX1X2; -O-CO-NX1X2; or -NX1X2; in which X1 represents an alkyl or phenyl which can be substituted, an alkoxy, or an optionally substituted cyclic or linear amine; a hydroxyl or carboxylic acid group; and Z represents a heterocycle containing one or more heteroatoms chosen from O, S and N, condensed with an aromatic ring which can also contain a heteroatom and which can be substituted, as well as their addition salts.
Patent IL-111322-A0 (IL)
Title: Type beta platelet-derived growth factor receptorgene
IPC: C07K16/22
Filed: 1994-10-18
Abstract: A human  alpha -platelet-derived growth factor receptor ( alpha -PDGFR) protein has the amino acid sequence: (a) beginning at amino acid 1 and ending with amino acid 1089 as shown in the accompanying Figure; (b) beginning at amino acid 24 and ending with amino acid 1089 as shown in the Figure; or (c) beginning at amino acid 959 and ending with amino acid 973 as shown in the Figure. An isolated human beta -platelet-derived growth factor receptor ( beta -PDGFR) protein consists of amino acids 967-981 of the human  beta -PDGFR protein. Antibodies to the  alpha -PDGFR protein may be used in an immunoassay for the detection of  alpha -PDGFR antigen in a biological sample. Antibodies to the  beta -PDGFR protein may be used in an immunoassay for the detection of  beta -PDGFR antigen in a biological sample. <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>   <IMAGE>
Patent IL-129586-A0 (IL)
Title: Artificial ventilation system and methods of controlling carbon dioxide rebreathing
IPC: A61M16/01
Filed: 1997-10-30
Abstract: A unilimb respiration device respiratory or ventilator conduit comprising a tube having a proximal end and a distal end,   the tube being operatively connectable at the proximal end to a first respiratory port providing inspiratory gas and to a second respiratory port for exhausting expiratory gas, and having the distal end directed towards the patient in use, the entire length of the tube providing a chamber having a predetermined dead space for mixing inspiratory and expiratory gases, said dead space being between 40 cubic centimetres and 1000 cubic centimetres, or the tube having a diameter between 11 millimeters and 28 millimeters and a length between 5 centimeters and 1.5 meters.
Patent IL-131512-A0 (IL)
Title: Adaptive sensory-motor encoder for visual or acoustic protheses
IPC: H04N5/232
Filed: 1998-02-20
Abstract: The encoder has the signals provided by a photosensor array fed to a stimulation and registration interface, provided by an implanted microcontact structure, via adjustable receptive field characteristic filters. The latter receive signals provided by the stimulation and registration interface, for providing an active vision function. The photosensor array may be incorporated in a spectacles frame, with image tracking movement controlled via head and eye movement detectors.
Patent IL-139193-A0 (IL)
Title: Method, apparatus and system for filling containers
IPC: B65B39/00
Filed: 1999-04-21
Abstract: A filling apparatus for, a filling system for and a method of introducing into a container a suspension or solution of a substance, in particular a pharmaceutical substance, in a propellant under pressure, the filling apparatus comprising: a main body (4) including a passageway (20) for communicating, in use, with a valve stem (144) extending from a head (141) of a body (139) of a container (138), the container (138) comprising a metering chamber (143) selectively communicatable by the valve stem (144) with the atmosphere and a storage chamber (140) defined by the body (139); a fill actuator (7) comprising a filling valve assembly (29) in communication with the passageway (20) for selectively introducing thereinto propellant under pressure containing a substance in a suspension or solution; an exhaust actuator (10) comprising an exhaust valve assembly (48) in communication with the passageway (20) for selectively exhausting therefrom propellant under pressure containing substance; and a container-engaging body (16) in communication with the passageway (20) for receiving, in use, the head (141) of the body (139) of the container (138), the container-engaging body (16) being movable relative to the main body (4) so as thereby to cause the valve stem (144) of the container (138) to be selectively positioned in an extended closed position, a depressed open position or an intermediate position therebetween, in which intermediate position the metering chamber (143) of the container (138) is closed to the atmosphere.
Patent IL-147442-A0 (IL)
Title: Promotion or inhibition of angiogenesis and cardiovscularization by tumor necrosis factor ligand/receptor homologs
IPC: A61P17/06
Filed: 2000-07-11
Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.
Patent IL-153941-A0 (IL)
Title: Technique for power control in optical networks
IPC: H04B10/17
Filed: 2003-01-14
Abstract: A technique for maintaining a required value of power per optical communication channel in a chain of optical nodes (112, 114, 118, 116) connected by optical fiber spans (111, 119, 121), wherein at least some of the nodes include optical amplifiers (112, 114, 116) with controllable gains, the technique comprises performing automatic gain control at the optical amplifiers so that, in the frame of power gain of each particular optical amplifier (114, 116), to compensate a preceding span loss. The span loss is calculated as power loss on an optical fiber span (111, 121) incoming the particular amplifier. <IMAGE>
Patent IL-162820-A0 (IL)
Title: Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
IPC: C07D401/04
Filed: 2002-12-18
Abstract: The present invention provides the combined use of acryloyl distamycin derivatives, in particular alpha-bromo- and alpha-chloro-acryloyl distamycin derivatives of formula (I), as set forth in the specification, and a protein kinase (serine/threonine and tyrosine kinases) inhibitor, in the treatment of tumors. Also provided is the use of the said combinations in the treatment or prevention of metastasis or in the treatment of tumors by inhibition of angiogenesis.
Patent IL-163635-A0 (IL)
Title: Device for treating a wound in the skin of a patient
IPC: A61F13/02
Filed: 2002-12-20
Abstract: A device (1, 14, 15, 18) for treating a wound (3) in the skin (2) of a patient by exposing the wound to a medium which stimulates the healing process, which device comprises at least one wall (4) which can be connected in an at least substantially fluid-tight manner to skin tissue surrounding the wound (3) so as to form an at least substantially fluid-tight space (13) between the wound (3) and the wall (4), a fluid inlet (8) for introducing said medium into said space (13), and a fluid outlet (9), wherein the wall area that is to cover the wound (3) is provided with spacers (5) extending towards the wound (3), which spacers (5) are intended to rest on the wound (3) so as to keep at least part of the wall (4) spaced from the wound (3).
Patent IL-176741-A0 (IL)
Title: Device for holding a fluidic component
IPC: B05B1/00
Filed: 2006-07-06
Abstract: A fluidic component is arranged in an elastomeric shaped part the contour of which is matched to the outer contour of the component and to the inner contour of a holder. The elastomeric shaped part is chamfered towards the fluidic component on its pressure side. When the holder is assembled the elastomeric shaped part is deformed by a projection provided on a mating part and is put under uniformly distributed internal tension, after which the elastomeric shaped part surrounds the fluidic component to its full height.
Patent IL-188967-A0 (IL)
Title: Vapour-sterisable blood separating device
Filed: 2008-01-23
Abstract: A device for separating blood into individual components and/or groups of components, in the form of a sterilizable system includes a filter arrangement forming inlet and outlet chambers using filter elements arranged therein, and respective receptacles for cellular blood components and for blood plasma. The inlet chamber can be connected to the blood source via a line on the inlet side to conduct the blood and is connected, on the outlet side, to the cellular blood components receptacle. The outlet chamber is connected to the blood plasma receptacle via a line on the outlet side. Thermal sterilization is used to sterilize the device by opening a respective line into the inlet-side line of the inlet chamber, into the inlet chamber and the outlet-side line of the outlet chamber, or into the outlet chamber, the line being connected to the exterior via a hydrophobic or hydrophilic filter.
Patent IL-210137-A0 (IL)
Title: Compositions containing fluorine substituted olefins
IPC: C11D7/50
Filed: 2010-12-21
Abstract: A method of sterilizing an article comprises contacting said article with a composition comprising at least one fluoroalkene of Formula I:  
 XCF z R 3-z (I)  
where X is a C 2  or a C 3  unsaturated, substituted or unsubstituted, alkyl radical, R is independently Cl, F, Br, I or H, and z is 1 to 3.
Patent RO-135335-A0 (RO)
Title: Innovative system for identification and characterization of microplastics in water by raman spectrometry
Inventor: UDREA VIRGIL MIRCEA
IPC: G01N33/18
Filed: 2021-03-31
Abstract: The invention relates to a system for identification and characterization of microplastics in water by Raman spectrometry. According to the invention, the system comprises: a spectrometer with focal number f/3, provided with an anti-reflective treated optical lens meant to reduce optical aberrations below the diffraction limit and a VPH (Volume Phase Holographic) diffraction network which reduces dependence on polarization and internal scattering to minimum, a CCD detector with thermoelectric cooling, a laser emitting on a wavelength of 785 nm with a power of 600 mW and a Raman sample coupled to the laser and the spectrometer by optic fibres and SMA connection.
Patent AP-2002002480-A0 (AP)
Title: Purine derivatives.
Inventor: MONAGHAN SANDRA MARINA
IPC: A61P17/00
Filed: 2000-10-06
Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists.
Patent MA-23233-A1 (MA)
Inventor: MICHAEL EUGENE BURNS
IPC: D06L3/02
Filed: 1994-06-23
Abstract: Laundry detergents and bleaching systems comprise acyl valerolactam bleach activators. The bleach activators are effective under mixed soil conditions, especially mixtures of hydrophobic and hydrophilic soils and stains.
Patent MA-27211-A1 (MA)
Title: Procede de montage/demontage de composants d'une centrale eolienne
Inventor: ALOYS WOBBEN
IPC: F03D1/06
Filed: 2004-11-30
Abstract: La présente invention concerne une centrale éolienne et un procédé permettant le montage/démontage de composants de ladite centrale. Afin de réduire la nécessité d'une grue lors du montage/démontage de composants d'une centrale éolienne, la centrale éolienne selon l'invention présente au moins une ouverture de passage pour un c??ble dans la zone de la tête de tour, permettant le passage d'un c??ble de traction depuis un treuil. De plus, le problème est résolu par un procédé permettant le montage/démontage de composants d'une centrale éolienne, comprenant les étapes suivantes: - pose d'un c??ble de traction depuis le treuil jusqu'à au moins une poulie de renvoi dans la zone de la tête de tour et ensuite jusqu'au composant devant être monté/démonté, - amarrage du c??ble de traction au composant et - démontage et descente ou remontée et montage du composant. L'invention est basée sur la reconnaissance du fait qu'au moins une partie des composants d'une centrale éolienne peuvent être montés ou remplacés sans assistance d'une grue, si l'on dispose d'un système de levage adéquat. La solution proposée par l'invention évite aux centrales éoliennes des installations supplémentaires onéreuses. Nonobstant, un système de levage d'utilisation multiple est rapidement disponible sans grands efforts.
Patent MA-20150150-A1 (MA)
Title: Bruleur d'ethanol multireservoirs autonomes avec portes reglables
Inventor: DASSOULI AZEDDINE
IPC: F23C6/00
Filed: 2013-10-28
Abstract: Leprincipede l 'invention est qu'il s 'pgit d 'un récipientà réservoirs multiples (deux ou plus)autonomes avec des portes d 'ouverture et defermeture réglables, glissantes et séparée. L'intérêt de ce nouveau dispositif c 'est qu'il assure une grande sécurité au momentde l'allumage, du réglage et de l'extinction de laflamme. Autre part une grande maitrise totale de la consommation du combustible. :
Patent MA-45894-A1 (MA)
Title: Système et procédé d'exécution d'opérations dans un environnement hétérogène et flexible implémenté dans une architecture basée sur la technologie blockchain
Inventor: OUAGUID ABDELLAH
IPC: G06Q20/00
Filed: 2019-05-21
Abstract: L'invention concerne un procédé et un système d'exécution d'opérations, permettant à un nœud de blockchain d'exécuter un ensemble d'opérations dans un environnement variable et flexible selon le besoin. Ces opérations sont assurées par un programme (ou plusieurs) hébergé dans des nœuds du réseau blockchain, ou par un programme externe (un smartcontrat par exemple). Selon le fonctionnement typique de la technologie blockchain, les nœuds exécutent le même programme dans un environnement identique qui, généralement, n'impacte pas le résultat des traitements, et tout résultat différent aux autres résultats trouvés par la majorité des nœuds du réseau blockchain, est considéré comme non valide ou "frauduleux". Or, notre conception consiste à ce que le programme exécuté doit prendre en considération l'environnement d'exécution. Dans le cas d’un résultat différent à celui trouvé par la majorité, les nœuds de la blockchain adoptent le même environnement jugé "incriminé" du nœud "suspect" et exécutent les mêmes opérations. Cette approche permettra à identifier et à signaler les programmes polymorphiques, dont l'exécution est susceptible de générer des résultats différents selon l'environnement d'exécution. La conception proposée est une solution basée sur la technologie blockchain (ou équivalent) et qui prend en considération les résultats générés par des programmes polymorphiques, ce qui réduise l'infirmation des résultats jugés, à tord, frauduleux.
Patent MA-50004-A1 (MA)
Title: Recuperation des colorants contenus dans des eaux colorées
Inventor: RACHID CHEROUAKI
IPC: C09D11/32
Filed: 2020-06-10
Abstract: La présente invention concerne un procédé de récupération des colorants, comprenant les étapes suivantes : on prélève un rejet coloré - on trie ce rejet coloré selon la famille de chaque colorant :soit acide, basique ou selon la nature de rejet coloré- on change le ph de certains eau colorées -on verse les volumes de chaque eau colorée dans le réacteur solaire –on couvre le réacteur par un couvercle ténébreux - on bombarde des radiations solaire concentré sur le réacteur– on récupère la matière sédimentée des colorants dans le réacteur solaire– on récupère l’eau distillé durant le temps d’évaporation -on récupère les colorants sous forme de poudre après un séchagel’invention concerne encore un dispositif pour la mise en œuvre dudit procédé.
Patent UY-29029-A1 (UY)
Title: Uso de tinturas de cianina para el diagnóstico de enfermedades asociadas con angiogénesis
Inventor: SCHIRNER MICHAEL
Filed: 2005-07-21
Abstract: Uso de conjugados de tinturas de cianina con un componente ligante específico para angiogénesis, preferiblemente con un componente ligante específico para EB-Dfibronectina para el diagnóstico de micrometástasis y pequenas lesiones proliferativas, en particular tumores primarios, precancerosis, displasia, metaplasia, lesiones inflanatorias, por ejemplo psoriasis, artritis psoriásica y/o artritis reumatoide, lesiones endometriósicas, y enfermedades oculares asociadas con angiogénesis.
Patent UY-30046-A1 (UY)
Title: Nuevos derivados de furopirimidina acíclicos sustitiudos y su uso
Inventor: MEININGHAUS DR MARK
IPC: A61P9/00
Filed: 2006-12-20
Abstract: La presente solicitud se refiere a nuevos derivados de furopirimidina acíclicos sustituidos, a procedimientos para su preparación, a su uso para el tratamiento y/o la profilaxis de enfermedades, así como a su uso para la preparación de fármacos para el tratamiento y/o la profilaxis de enfermedades, especialmente para el tratamiento de enfermedades cardiovasculares.
Patent UY-30291-A1 (UY)
Title: Piridin(3,4-b)pirazinonas
Inventor: WALKER JOHN KEITH
IPC: A61P9/12
Filed: 2007-04-18
Abstract: Se dan a conocer compuestos y sales farmacéuticamente aceptables de los compuestos, en los que los compuestos tienen la estructura de Formula I: en la que R2, R6A, R6B, y R8 son como se definen en esta memoria descriptiva. Se dan a conocer también las correspondientes composiciones farmacéuticas, procedimientos de tratamiento, procedimientos sintéticos e intermedos.
Patent ZW-22283-A1 (ZW)
Title: Antiviral compounds
Inventor: HOWARD JOHN SCHAEFFER
IPC: A61K31/52
Filed: 1983-10-13
Abstract: Compounds of the general formula <CHEM> (wherein X is sulphur or oxygen or a chemical bond; R<1> is halogen, amino or azido; R<2> is hydrogen, hydroxy, alkyl or hydroxyalkyl; R<3> is hydrogen or alkyl; R<4> is hydroxy, hydroxyalkyl, benzyloxy, phosphate or carboxypropionyloxy; R<5> is hydrogen, alkyl or hydroxyalkyl) and salts and esters thereof, have been found to have valuable antiviral activity particularly against herpes viruses. Methods for the preparation of the above compounds are described as well as pharmaceutical formulations containing such compounds.
Patent ES-172129-A1 (ES)
Title: UN DISPOSITIVO DIFERENCIAL ELECTROMECáNICO DE TRANSMISIoN DE ENERGiA CON REGULACIoN CONTINUA DE VELOCIDAD, COMBINADO O NO CON CAMBIO DE VELOCIDADES MECáNICO
Filed: 1946-01-11
Abstract: Dispositivo diferencial electro-mecánico de transmisión de energía con regulación continua de velocidad combinado o no con un cambio de velocidades y que tiene por lo menos unas máquinas eléctricas acoplada por lo menos indirectamente y mediante un juego por lo menos de engranajes diferenciales con una fuente por lo menso de energía mecánica y con una máquina a arrastrar por lo menos caracterizado por el hecho de que por lo menos una máquina eléctrica es excitada por menos parcialmente por medio de un bobinado cuya corriente no depende de la corriente principal de esta máquina siendo dicho bobinado alimentado por lo menos en parte por una corriente función del movimiento de uno de los árboles del diferencia distinto de aquél a que la máquina considerada está acoplada por lo menos indirectamente de tal manera que tal excitación en función del movimiento de un árbol cuya velocidad no es proporcional a la de la máquina a excitar.